Table 1.
Cohort demographics (N = 21)
Breast cancer (N = 8) | Prostate cancer (N = 13) | |
---|---|---|
Age, median (IQR) | 66 years (58–68.5 years) | 61 years (58–65 years) |
Gender | ||
Male | 8 (100%) | 13 (100%) |
Female | ||
Race/ethnicity | ||
White, non-Hispanic | 8 (100%) | 10 (76.9%) |
White, Hispanic | 2 (15.4%) | |
Asian American | 1 (7.7%) | |
Married | 6 (75%) | 13 (100%) |
Primary insurance provider | ||
Employer-sponsored Insurance | 4 (50%) | 6 (30.8%) |
Medicare | 4 (50%) | 4 (46.2%) |
Tricare | 1 (7.7%) | |
Medicaid | 2 (15.4%) | |
Breast cancer stage | ||
Ductal carcinoma in situ (DCIS) | 1 (12.5%) | |
Stage I, estrogen-receptor+ (ER+) | 7 (87.5%) | |
Prostate cancer grade | ||
High grade | 1 (7.7%) | |
Intermediate grade | 10 (76.9%) | |
Low grade | 2 (15.4%) | |
Surgery | ||
Lumpectomy | 6 (75%) | |
Double mastectomy | 2 (25%) | |
Prostatectomy | 13 (100%) |